Literature DB >> 17574754

Divergent effects of prostaglandin receptor signaling on neuronal survival.

Liejun Wu1, Qian Wang, Xibin Liang, Katrin Andreasson.   

Abstract

Induction of cyclooxygenase-2 (COX-2) with production of prostaglandins occurs in a wide spectrum of acute and chronic neurodegenerative diseases and is associated with neuronal death. Inhibition of the COX-2 pathway and downstream production of prostaglandins protect neurons in rodent models of cerebral ischemia and neurodegeneration. Recent studies investigating the functions of selected prostaglandin receptor pathways in mediating COX-2 neurotoxicity have demonstrated both toxic and paradoxically neuroprotective effects of several receptors in models of excitotoxicity. In this study, we investigate the functions of additional prostaglandin receptors not previously characterized in organotypic models of glutamate excitotoxicity. We find that PGD(2), PGI(2), and PGF(2alpha) receptors protect motor neurons in an organotypic spinal cord model of amyotrophic lateral sclerosis (ALS). In addition, PGI(2) and TXA(2) receptors rescue CA1 neurons in an organotypic hippocampal model of N-methyl-d-aspartate excitotoxicity. However, in a model of inflammation induced by lipopolysaccharide, prostaglandin receptors previously found to be protective in excitotoxicity now cause CA1 neuronal death. Taken together, these studies identify novel eicosanoid receptor signaling pathways that mediate neuronal protection in excitotoxic paradigms; these data also support the emerging hypothesis that the toxic/protective effects of eicosanoid signaling on neuronal viability diverge significantly depending on whether excitotoxicity or inflammation predominates as the underlying toxic stimulus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574754      PMCID: PMC2680717          DOI: 10.1016/j.neulet.2007.05.055

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  24 in total

1.  PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis.

Authors:  Masako Bilak; Liejun Wu; Qian Wang; Norman Haughey; Katherine Conant; Coryse St Hillaire; Katrin Andreasson
Journal:  Ann Neurol       Date:  2004-08       Impact factor: 10.422

2.  Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity.

Authors:  Takayuki Kawano; Josef Anrather; Ping Zhou; Laibaik Park; Gang Wang; Kelly A Frys; Alexander Kunz; Sunghee Cho; Marcello Orio; Costantino Iadecola
Journal:  Nat Med       Date:  2006-01-06       Impact factor: 53.440

Review 3.  Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models.

Authors:  Francesca Bosetti
Journal:  J Neurochem       Date:  2007-04-02       Impact factor: 5.372

Review 4.  The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs.

Authors:  Jeroen J M Hoozemans; M Kerry O'Banion
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2005-06

5.  Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia.

Authors:  Dong Liu; Liejun Wu; Richard Breyer; Mark P Mattson; Katrin Andreasson
Journal:  Ann Neurol       Date:  2005-05       Impact factor: 10.422

Review 6.  Role of inflammation in neurodegenerative diseases.

Authors:  Luisa Minghetti
Journal:  Curr Opin Neurol       Date:  2005-06       Impact factor: 5.710

7.  Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice.

Authors:  K I Andreasson; A Savonenko; S Vidensky; J J Goellner; Y Zhang; A Shaffer; W E Kaufmann; P F Worley; P Isakson; A L Markowska
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

8.  Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids.

Authors:  K Yamagata; K I Andreasson; W E Kaufmann; C A Barnes; P F Worley
Journal:  Neuron       Date:  1993-08       Impact factor: 17.173

9.  Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.

Authors:  Louise McCullough; Liejun Wu; Norman Haughey; Xibin Liang; Tracey Hand; Qian Wang; Richard M Breyer; Katrin Andreasson
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

10.  Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury.

Authors:  Hidetoshi Taniguchi; Ikuko Mohri; Hitomi Okabe-Arahori; Kosuke Aritake; Kazuko Wada; Takahisa Kanekiyo; Shuh Narumiya; Masahiro Nakayama; Keiichi Ozono; Yoshihiro Urade; Masako Taniike
Journal:  J Neurosci       Date:  2007-04-18       Impact factor: 6.167

View more
  24 in total

1.  Neuronal overexpression of cyclooxygenase-2 does not alter the neuroinflammatory response during brain innate immune activation.

Authors:  Saba Aid; Nishant Parikh; Sara Palumbo; Francesca Bosetti
Journal:  Neurosci Lett       Date:  2010-05-06       Impact factor: 3.046

2.  Function of prostaglandin E2 EP receptors in the acute outcome of rodent hypoxic ischemic encephalopathy.

Authors:  Hidetoshi Taniguchi; Christoph Anacker; Gabriela Beatriz Suarez-Mier; Qian Wang; Katrin Andreasson
Journal:  Neurosci Lett       Date:  2011-09-12       Impact factor: 3.046

3.  Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection.

Authors:  David T Stark; Nicolas G Bazan
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

4.  Prostaglandin signalling in cerebral ischaemia.

Authors:  Katrin Andreasson
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

5.  Inhibition of Cyclooxygenase-2 (COX-2) Initiates Autophagy and Potentiates MPTP-Induced Autophagic Cell Death of Human Neuroblastoma Cells, SH-SY5Y: an Inside in the Pathology of Parkinson's Disease.

Authors:  Rituraj Niranjan; Kaushal Prasad Mishra; Ashwani Kumar Thakur
Journal:  Mol Neurobiol       Date:  2018-03-01       Impact factor: 5.590

6.  Prostaglandin E2 Produced by Alginate-Encapsulated Mesenchymal Stromal Cells Modulates the Astrocyte Inflammatory Response.

Authors:  Elizabeth C Stucky; Joshua Erndt-Marino; Rene S Schloss; Martin L Yarmush; David I Shreiber
Journal:  Nano Life       Date:  2017-06

7.  The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis.

Authors:  Xibin Liang; Qian Wang; Ju Shi; Ludmila Lokteva; Richard M Breyer; Thomas J Montine; Katrin Andreasson
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

8.  Ablation of the microglial protein DOCK2 reduces amyloid burden in a mouse model of Alzheimer's disease.

Authors:  Patrick J Cimino; Yue Yang; Xianwu Li; Jake F Hemingway; Makenzie K Cherne; Shawn B Khademi; Yoshinori Fukui; Kathleen S Montine; Thomas J Montine; C Dirk Keene
Journal:  Exp Mol Pathol       Date:  2013-01-11       Impact factor: 3.362

Review 9.  Pathophysiological Roles of Cyclooxygenases and Prostaglandins in the Central Nervous System.

Authors:  Tatsurou Yagami; Hiromi Koma; Yasuhiro Yamamoto
Journal:  Mol Neurobiol       Date:  2015-09-02       Impact factor: 5.590

10.  Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia.

Authors:  Jun Li; Xibin Liang; Qian Wang; Richard M Breyer; Louise McCullough; Katrin Andreasson
Journal:  Neurosci Lett       Date:  2008-04-20       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.